These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31100011)

  • 1. The adaptive immune role of metallothioneins in the pathogenesis of diabetic cardiomyopathy: good or bad.
    Ge T; Yu Y; Cui J; Cai L
    Am J Physiol Heart Circ Physiol; 2019 Aug; 317(2):H264-H275. PubMed ID: 31100011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic cardiomyopathy and its prevention by metallothionein: experimental evidence, possible mechanisms and clinical implications.
    Cai L
    Curr Med Chem; 2007; 14(20):2193-203. PubMed ID: 17691957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metallothioneins: Emerging Modulators in Immunity and Infection.
    Subramanian Vignesh K; Deepe GS
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29065550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustaining Circulating Regulatory T Cell Subset Contributes to the Therapeutic Effect of Paroxetine on Mice With Diabetic Cardiomyopathy.
    Han Y; Lai J; Tao J; Tai Y; Zhou W; Guo P; Wang Z; Wang M; Wang Q
    Circ J; 2020 Aug; 84(9):1587-1598. PubMed ID: 32741881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4
    Wei Y; Yu K; Wei H; Su X; Zhu R; Shi H; Sun H; Luo Q; Xu W; Xiao J; Zhong Y; Zeng Q
    Immunology; 2017 Jul; 151(3):291-303. PubMed ID: 28207945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of impaired zinc homeostasis in diabetic cardiomyopathy and nephropathy.
    Giacconi R; Cai L; Costarelli L; Cardelli M; Malavolta M; Piacenza F; Provinciali M
    Biofactors; 2017 Nov; 43(6):770-784. PubMed ID: 28845600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metallothionein as an adaptive protein prevents diabetes and its toxicity.
    Cai L
    Nonlinearity Biol Toxicol Med; 2004 Apr; 2(2):89-103. PubMed ID: 19330125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metallothioneins (MTs) in the human eye: a perspective article on the zinc-MT redox cycle.
    Gonzalez-Iglesias H; Alvarez L; García M; Petrash C; Sanz-Medel A; Coca-Prados M
    Metallomics; 2014 Feb; 6(2):201-8. PubMed ID: 24419560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of ERK1/2 in the Development of Diabetic Cardiomyopathy.
    Xu Z; Sun J; Tong Q; Lin Q; Qian L; Park Y; Zheng Y
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27941647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging Roles of Metallothioneins in Beta Cell Pathophysiology: Beyond and Above Metal Homeostasis and Antioxidant Response.
    Bensellam M; Laybutt DR; Jonas JC
    Biology (Basel); 2021 Feb; 10(3):. PubMed ID: 33652748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of Impaired Insulin Signaling to the Pathogenesis of Diabetic Cardiomyopathy.
    Zamora M; Villena JA
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31212580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zinc, T-cell pathways, aging: role of metallothioneins.
    Mocchegiani E; Muzzioli M; Cipriano C; Giacconi R
    Mech Ageing Dev; 1998 Dec; 106(1-2):183-204. PubMed ID: 9883983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc rescue of Akt2 gene deletion-linked murine cardiac dysfunction and pathological changes is metallothionein-dependent.
    Sun W; Miao X; Zhou S; Zhang L; Epstein PN; Mellen N; Zheng Y; Fu Y; Wang Y; Cai L
    J Mol Cell Cardiol; 2014 Sep; 74():88-97. PubMed ID: 24819347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metallothionein regulates intracellular zinc signaling during CD4(+) T cell activation.
    Rice JM; Zweifach A; Lynes MA
    BMC Immunol; 2016 Jun; 17(1):13. PubMed ID: 27251638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.
    Palomer X; Salvadó L; Barroso E; Vázquez-Carrera M
    Int J Cardiol; 2013 Oct; 168(4):3160-72. PubMed ID: 23932046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irisin inhibits high glucose-induced endothelial-to-mesenchymal transition and exerts a dose-dependent bidirectional effect on diabetic cardiomyopathy.
    Liu X; Mujahid H; Rong B; Lu QH; Zhang W; Li P; Li N; Liang ES; Wang Q; Tang DQ; Li NL; Ji XP; Chen YG; Zhao YX; Zhang MX
    J Cell Mol Med; 2018 Feb; 22(2):808-822. PubMed ID: 29063670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zinc, metallothioneins, immune responses, survival and ageing.
    Mocchegiani E; Muzzioli M; Giacconi R
    Biogerontology; 2000; 1(2):133-43. PubMed ID: 11707929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T cells in cardiovascular diseases.
    Meng X; Yang J; Dong M; Zhang K; Tu E; Gao Q; Chen W; Zhang C; Zhang Y
    Nat Rev Cardiol; 2016 Mar; 13(3):167-79. PubMed ID: 26525543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diazoxide preconditioning of endothelial progenitor cells from streptozotocin-induced type 1 diabetic rats improves their ability to repair diabetic cardiomyopathy.
    Ali M; Mehmood A; Anjum MS; Tarrar MN; Khan SN; Riazuddin S
    Mol Cell Biochem; 2015 Dec; 410(1-2):267-79. PubMed ID: 26359087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac metallothionein induction plays the major role in the prevention of diabetic cardiomyopathy by zinc supplementation.
    Wang J; Song Y; Elsherif L; Song Z; Zhou G; Prabhu SD; Saari JT; Cai L
    Circulation; 2006 Jan; 113(4):544-54. PubMed ID: 16432057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.